Liver organoids have change into an vital instrument for finding out human liver biology, illness mechanisms, drug responses, irritation, and regenerative drugs. Conventional two-dimensional liver cell cultures can present helpful info, however they usually fail to breed the advanced mobile communication that happens inside native liver tissue. The liver will not be made from hepatocytes alone. It incorporates epithelial, endothelial, mesenchymal, and immune cell populations that work together repeatedly to control metabolism, immune protection, damage response, and tissue restore.
Amongst these cell varieties, Kupffer cells are particularly vital. Kupffer cells are liver-resident macrophages. They assist detect pathogens, clear particles, course of antigens, regulate irritation, and take part in liver restore and regeneration. Due to these capabilities, they’re central to liver pathogenesis in situations equivalent to sepsis-related liver dysfunction, inflammatory liver damage, metabolic liver illness, fibrosis, and infection-associated hepatic stress.
A latest STAR Protocols article by Yang Li, Yunzhong Nie, and Hideki Taniguchi describes a protocol for producing human induced pluripotent stem cell-derived liver organoids containing Kupffer cells, additionally referred to as KuLOs. The workflow integrates Kupffer cell progenitors into liver organoids by producing a number of cell lineages from human iPSCs after which combining them in a scaffold-free organoid co-culture system.
What Are Liver Organoids Containing Kupffer Cells?
Liver organoids containing Kupffer cells are three-dimensional liver-like buildings that embody each hepatic and immune parts. Within the protocol described by Li and colleagues, the organoids are generated from human iPSCs and comprise a number of iPSC-derived lineages:
| Cell Element | Function within the Organoid Mannequin |
|---|---|
| Hepatic endoderm | Offers rise to liver epithelial or hepatocyte-like parts |
| Endothelial cells | Help vascular-like signaling and tissue group |
| Mesenchymal cells | Present stromal help and developmental cues |
| Erythroid-myeloid progenitors | Function Kupffer cell progenitors |
| Kupffer-like macrophages | Present liver-resident immune capabilities |
The ensuing organoids are known as KuLOs, which means Kupffer cell-containing liver organoids.
The important thing benefit of this mannequin is that it doesn’t deal with the liver as a purely epithelial organ. As an alternative, it incorporates tissue-resident macrophage biology into the organoid system. This makes the mannequin extra related for finding out liver irritation, immune-mediated hepatic dysfunction, and restoration after inflammatory damage.
Why Kupffer Cells Matter in Liver Organoid Fashions
Kupffer cells are among the many most considerable resident macrophage populations within the human physique. They’re strategically positioned within the liver to observe blood coming into from the portal vein and hepatic artery. This exposes them to vitamins, microbial merchandise, toxins, immune alerts, and circulating particles.
Their capabilities embody:
- Detecting inflammatory and microbial alerts
- Clearing apoptotic cells and broken materials
- Producing cytokines and chemokines
- Supporting liver restore and regeneration
- Taking part in iron dealing with and antigen processing
- Modulating hepatocyte operate throughout irritation
- Contributing to liver damage when immune activation turns into extreme
As a result of Kupffer cells can both shield the liver or contribute to damage relying on context, together with them in organoid fashions is effective. A hepatocyte-only organoid could present metabolic exercise, nevertheless it can’t absolutely mannequin immune-driven hepatic dysfunction. A Kupffer cell-containing organoid can higher symbolize how immune activation impacts liver operate.
That is notably vital for modeling sepsis-associated liver dysfunction, the place systemic irritation and endotoxin publicity can impair hepatic operate. Within the KuLO system, endotoxin stimulation can activate Kupffer cells, set off inflammatory cytokine launch, and scale back hepatic efficiency. This offers a managed human-cell platform for finding out inflammation-related liver damage and restoration.
Why Use Human iPSCs for Producing KuLOs?
Human induced pluripotent stem cells are helpful as a result of they are often expanded and differentiated into many cell varieties. In organoid analysis, iPSCs present a versatile beginning materials for creating advanced, multicellular fashions.
Utilizing human iPSCs presents a number of benefits:
1. Human Organic Relevance
Animal fashions are precious however don’t at all times reproduce human liver improvement, immune signaling, drug metabolism, or inflammatory responses. Human iPSC-derived fashions will help bridge this hole.
2. Multilineage Differentiation
The KuLO protocol makes use of iPSCs to generate a number of cell lineages wanted for organoid meeting, together with hepatic endoderm, endothelial cells, mesenchymal cells, and erythroid-myeloid progenitors.
3. Reproducibility and Scalability
iPSC-derived techniques will be expanded and standardized extra successfully than many main human tissue techniques, though line-to-line variability nonetheless must be managed.
4. Illness Modeling Potential
Affected person-specific or genetically edited iPSC strains could also be used to check inherited liver issues, immune dysregulation, inflammatory susceptibility, or disease-associated variants.
5. Drug Testing and Therapeutic Screening
As a result of KuLOs mix hepatic and immune components, they might help testing of compounds that modulate irritation, hepatocyte operate, macrophage activation, or liver restoration.
Overview of the KuLO Technology Technique
The protocol described by Li and colleagues follows a developmental logic. As an alternative of merely including mature macrophages to preformed organoids, it generates erythroid-myeloid progenitors, or EMPs, from human iPSCs and incorporates them into liver organoids throughout co-culture.
This issues as a result of Kupffer cells come up developmentally from early myeloid progenitor populations. By integrating EMPs into the organoid system, the protocol goals to imitate points of tissue-resident macrophage improvement and integration.
The overall workflow will be summarized in 4 main phases:
- Put together and broaden high-quality human iPSCs
- Differentiate iPSCs into EMPs and hepatic endoderm
- Mix EMPs with hepatic, endothelial, and mesenchymal lineages
- Permit organoids to mature and characterize Kupffer cell integration
The ultimate KuLOs comprise a number of cell varieties and will be evaluated for hepatic maturation, Kupffer cell differentiation, immune activation, and useful restoration after inflammatory problem.
Section 1: Getting ready Human iPSCs for Differentiation
Profitable KuLO technology begins with high-quality human iPSC tradition. The protocol emphasizes that iPSCs must be wholesome, maintained beneath acceptable tradition situations, and passaged earlier than differentiation.
This step is vital as a result of poor iPSC high quality can scale back differentiation effectivity throughout a number of lineages. If iPSCs are confused, overgrown, spontaneously differentiated, or stored at extreme passage numbers, downstream hepatic and hematopoietic differentiation could also be compromised.
Essential high quality concerns embody:
- Sustaining iPSC colonies in an undifferentiated state
- Avoiding spontaneous differentiation earlier than beginning the protocol
- Utilizing acceptable extracellular matrix coating
- Controlling passage timing
- Utilizing iPSCs with preserved differentiation potential
- Coordinating separate differentiation timelines for various cell lineages
The protocol notes that hepatic endoderm and EMPs shouldn’t be cryopreserved for co-culture on this workflow. As an alternative, they’re really useful for recent use, whereas endothelial and mesenchymal progenitors could also be dealt with in accordance with beforehand established procedures.
This scheduling element issues. Organoid meeting is dependent upon having a number of cell lineages prepared on the identical time.
Section 2: Producing Erythroid-Myeloid Progenitors from Human iPSCs
One of many central improvements of the protocol is the environment friendly technology of erythroid-myeloid progenitors, or EMPs. These progenitors are used because the supply of Kupffer-like cells within the organoid system.
EMPs are vital as a result of they symbolize an early hematopoietic inhabitants with myeloid potential. Within the KuLO workflow, they’re differentiated from human iPSCs by way of a sequence designed to advertise hemogenic and myeloid lineage specification.
In the course of the differentiation course of, researchers monitor the emergence of related progenitor markers. The protocol highlights markers equivalent to:
- CD43
- CD34
- CD115, often known as CSF-1R
The goal EMP inhabitants is described as CD43-positive, CD34-positive, and CD115-positive. These markers assist affirm that the differentiation course of is producing an appropriate Kupffer cell progenitor inhabitants.
Circulate cytometry is used to look at differentiation effectivity. This is a vital quality-control checkpoint as a result of the success of Kupffer cell integration is dependent upon the standard and id of the EMP inhabitants.
If EMP differentiation is poor, the ultimate organoids could comprise fewer Kupffer-like cells or present inconsistent immune habits. The protocol recommends monitoring differentiation rigorously and optimizing iPSC seeding density and reagent high quality when yields are low.
Section 3: Producing Hepatic Endoderm from Human iPSCs
The hepatic element of the organoid begins with differentiation of human iPSCs into hepatic endoderm, usually abbreviated as HE. Hepatic endoderm represents a developmental stage on the trail towards hepatocyte-like cells.
The HE differentiation course of contains two broad phases:
- Definitive endoderm specification
- Hepatic endoderm differentiation
This displays regular developmental biology. Throughout embryonic improvement, liver tissue arises from definitive endoderm, which then receives alerts that drive hepatic specification.
Within the KuLO protocol, profitable HE differentiation is assessed utilizing morphology, circulate cytometry, and gene expression evaluation. By the top of the HE differentiation section, the cells are anticipated to point out hepatic endoderm traits, together with polygonal morphology and expression of related markers.
Essential HE markers embody:
- CD326, often known as EpCAM
- CD133
- HNF4A
- AFP
The protocol additionally notes that definitive endoderm markers equivalent to CXCR4 and CER1 are anticipated to point out transient expression throughout differentiation, whereas pluripotency genes equivalent to NANOG and POU5F1 ought to lower.
A robust HE inhabitants is crucial as a result of it kinds the hepatic basis of the organoid. Poor HE differentiation can result in failure of organoid formation, diminished hepatic operate, or poor maturation.
Section 4: Co-Culturing A number of iPSC-Derived Lineages to Generate KuLOs
After producing the required cell varieties, the protocol combines them in a scaffold-free co-culture system. The organoids are shaped in U-bottom microwell plates, which assist cells self-aggregate into three-dimensional buildings.
The principle cell populations used for KuLO technology are:
- iPSC-derived hepatic endoderm
- iPSC-derived endothelial cells
- iPSC-derived mesenchymal cells
- iPSC-derived erythroid-myeloid progenitors
The protocol recommends a lineage ratio during which hepatic endoderm is the dominant inhabitants, with endothelial, mesenchymal, and EMP populations included at decrease however significant proportions. The supplied ratio is 5:1:1:1 for HE, ECs, MCs, and EMPs respectively.
This co-culture design helps organoid formation whereas enabling EMP-derived macrophage improvement in and across the organoids. Throughout co-culture, EMPs broaden and differentiate towards a Kupffer-like phenotype. In the meantime, the liver organoids endure useful maturation.
The mannequin is designed in order that organoids progressively develop hepatic options whereas additionally incorporating immune-cell performance.
What Are KuLOs Anticipated to Include?
KuLOs are multicellular buildings. They aren’t composed of a single liver-like cell kind. Their worth comes from the interplay of a number of lineages.
Hepatic Cells
The hepatic element contributes liver-related capabilities, together with albumin secretion, expression of hepatic markers, and metabolic exercise.
Endothelial Cells
Endothelial cells assist symbolize vascular-associated signaling. Though the protocol notes that the endothelial community stays restricted in contrast with native liver tissue, this cell kind provides vital tissue complexity.
Mesenchymal Cells
Mesenchymal cells present stromal help and developmental cues. They might assist manage organoid structure and affect hepatic maturation.
Kupffer-Like Cells
The EMP-derived macrophage inhabitants differentiates towards a Kupffer-like phenotype, expressing markers equivalent to:
By roughly two weeks of co-culture, the protocol studies that almost all EMP-derived cells can categorical Kupffer-associated markers. These Kupffer-like cells contribute immune responsiveness and assist mannequin liver irritation.
Characterizing Kupffer Cells in Liver Organoids
Characterization is a serious a part of the KuLO protocol. Producing organoids will not be sufficient; researchers should affirm that the specified cell populations are current and useful.
A number of approaches are used.
Circulate Cytometry
Circulate cytometry helps analyze hematopoietic and Kupffer-like cell differentiation. The protocol recommends inspecting EMP-derived cells throughout co-culture and assessing Kupffer-associated markers equivalent to CD45, CD14, and CD163.
Circulate cytometry may assist distinguish different organoid cell populations utilizing lineage markers equivalent to:
- CD326 for hepatic cells
- CD31 for endothelial cells
- CD45 for hematopoietic cells
Nonetheless, the protocol notes that dissociation of organoids could not completely symbolize the precise mobile composition as a result of some cell clusters could stay undissociated.
Entire-Mount Immunostaining
Entire-mount immunostaining permits researchers to visualise organoids in three dimensions. This could present the spatial group of hepatic cells and Kupffer-like cells inside or across the organoid buildings.
Markers equivalent to hepatic proteins and macrophage markers can be utilized to substantiate multilineage group.
Hepatic Perform Assays
The organoids will be assessed for liver-like operate by way of readouts equivalent to:
- Albumin secretion
- Hepatic marker gene expression
- CYP3A4 enzyme exercise
- Ammonia metabolism
Albumin secretion is very helpful as a result of it offers a useful indicator of hepatic maturation over time. The protocol studies that albumin secretion will increase throughout co-culture and stabilizes as KuLOs mature.
Gene Expression Evaluation
Gene expression can be utilized to evaluate hepatic maturation, Kupffer cell id, inflammatory activation, and lineage-specific improvement. That is notably helpful for evaluating KuLOs with organoids missing Kupffer cells or with main liver tissue references.
Anticipated Outcomes of KuLO Technology
The anticipated consequence is a useful human iPSC-derived liver organoid system containing Kupffer-like cells. These organoids embody progenitors and differentiated cells from a number of lineages and might mannequin immune-hepatic interactions.
By roughly day 14 of co-culture, KuLOs are anticipated to succeed in a extra mature state. At this stage, hepatic capabilities stabilize and EMP-derived cells present Kupffer cell marker expression.
Reported useful options embody:
- Elevated albumin secretion over time
- Upregulation of hepatic markers equivalent to ALB, A1AT, and CPS1
- CYP3A4 exercise
- Ammonia metabolism
- Differentiation of EMPs into Kupffer-like cells
- Enrichment of Kupffer-related capabilities equivalent to antigen processing and iron ion homeostasis
- Responsiveness to endotoxin-induced inflammatory stimulation
These outcomes make KuLOs a helpful platform for finding out how liver-resident macrophages affect hepatic operate throughout irritation.
Modeling Sepsis-Associated Liver Dysfunction
One of the vital purposes of KuLOs is modeling inflammation-associated liver dysfunction, together with situations associated to sepsis.
Sepsis is characterised by systemic irritation, immune dysregulation, and organ dysfunction. The liver is closely concerned as a result of it filters blood, responds to inflammatory mediators, produces acute-phase proteins, and regulates metabolism throughout systemic stress.
Within the KuLO mannequin, endotoxin stimulation can activate Kupffer-like cells. This could result in:
- Kupffer cell activation
- Professional-inflammatory cytokine launch
- Impaired hepatic operate
- Lowered liver organoid efficiency
- Restoration after removing of inflammatory stimuli
This makes KuLOs helpful for finding out each damage and restoration. Researchers can study how inflammatory alerts disrupt hepatocyte-like operate and the way tissue operate could also be restored after inflammatory mediators are eliminated.
One of these mannequin could also be precious for therapeutic screening. Compounds that scale back dangerous irritation or promote hepatic restoration could possibly be evaluated in a human multicellular organoid context.
Analysis Functions of Human iPSC-Derived KuLOs
1. Liver Irritation Analysis
KuLOs present a platform to check how Kupffer cells regulate inflammatory signaling inside liver-like tissue. That is helpful for exploring cytokine networks, macrophage activation states, and hepatocyte responses to immune stress.
2. Sepsis and Acute Liver Dysfunction
As a result of KuLOs can reply to endotoxin publicity, they’re helpful for modeling sepsis-like inflammatory liver dysfunction. Researchers can examine how immune activation impairs hepatic operate and the way restoration happens.
3. Liver Regeneration and Restore
Kupffer cells take part in liver restore after damage. KuLOs could assist researchers examine macrophage-derived alerts that help or inhibit liver regeneration.
4. Drug-Induced Liver Damage
Many drug-induced liver damage fashions focus totally on hepatocytes. Including Kupffer-like cells could assist mannequin immune-mediated liver toxicity or inflammatory amplification of drug responses.
5. Metabolic Liver Illness
Persistent liver illnesses equivalent to fatty liver illness contain interactions between hepatocytes, macrophages, endothelial cells, and stromal cells. KuLOs could help mechanistic research of inflammatory-metabolic crosstalk.
6. Fibrosis Analysis
Though KuLOs are usually not an entire fibrosis mannequin, the inclusion of mesenchymal cells and Kupffer-like cells could help future adaptation for finding out fibrogenic signaling and macrophage-stromal interactions.
7. Customized Medication
Affected person-specific iPSCs may theoretically be used to generate KuLOs for finding out particular person susceptibility to liver irritation, immune dysregulation, or genetic liver illness.
8. Therapeutic Screening
KuLOs could present a platform for testing anti-inflammatory brokers, hepatoprotective compounds, macrophage-modulating medication, or regenerative therapies.
Why This Protocol Is Progressive
The principle innovation is the combination of Kupffer cell progenitors into human iPSC-derived liver organoids by way of a developmental technique.
Many organoid techniques lack resident immune cells. This limits their capability to mannequin irritation and immune-tissue communication. Different strategies could add macrophages externally, however these approaches could not absolutely replicate tissue-resident macrophage integration.
The KuLO protocol addresses this by producing EMPs from iPSCs and co-culturing them with hepatic and supportive lineages. This permits Kupffer-like cells to emerge inside a growing organoid atmosphere.
The result’s a extra advanced liver mannequin that higher displays the multicellular nature of human liver tissue.
High quality Management Issues
Dependable KuLO technology is dependent upon a number of checkpoints.
iPSC High quality
Wholesome, undifferentiated iPSCs are important. Poor iPSC tradition high quality can scale back each hepatic and hematopoietic differentiation.
EMP Differentiation
The EMP inhabitants must be assessed utilizing markers equivalent to CD43, CD34, and CD115. Low EMP yield could scale back Kupffer cell formation.
HE Differentiation
Hepatic endoderm ought to present acceptable morphology and marker expression. Low HE high quality can impair organoid formation and hepatic maturation.
Organoid Formation
Cells ought to combination into spheroid-like buildings after seeding into microwells. Failure to type organoids could point out poor HE viability, insufficient cell preparation, or lacking survival-supporting situations.
Kupffer Cell Marker Expression
Kupffer-like differentiation must be monitored utilizing markers equivalent to CD45, CD14, and CD163.
Hepatic Perform
Albumin secretion, CYP exercise, ammonia metabolism, and hepatic gene expression will help assess organoid maturation.
Limitations of KuLO Fashions
Though KuLOs are an vital development, they aren’t excellent replicas of grownup human liver tissue.
Restricted Hepatocyte Maturity
The protocol notes that KuLOs present hepatic operate however stay much less mature than main human hepatocytes. It is a widespread limitation of many iPSC-derived hepatic techniques.
Incomplete Endothelial Community
The organoids comprise endothelial cells, however they don’t absolutely reproduce the advanced vascular structure of the liver. This will likely restrict purposes targeted on sinusoidal biology or vascular irritation.
Organoid Variability
Organoid measurement, cell composition, and maturation could range throughout wells, iPSC strains, and differentiation batches.
Technical Complexity
The workflow requires coordination of a number of cell lineages with completely different differentiation timelines. This will increase experimental complexity in contrast with easier organoid fashions.
Partial Immune Illustration
KuLOs embody Kupffer-like macrophages, however the liver immune atmosphere additionally incorporates different immune populations, equivalent to lymphocytes, neutrophils, dendritic cells, and circulating monocytes. These are usually not absolutely represented.
Troubleshooting Ideas
The protocol identifies a number of widespread issues and sensible causes.
Low EMP Differentiation Effectivity
Low EMP yield could end result from poor iPSC high quality, suboptimal beginning density, or degraded cytokines and development elements. The protocol recommends optimizing iPSC seeding density and utilizing recent or correctly saved dietary supplements.
Low HE Differentiation Effectivity
Poor HE differentiation can happen when iPSCs have diminished differentiation potential, when seeding density will not be optimum, or when development elements lose exercise. Marker evaluation and morphology checks are vital for diagnosing this drawback.
Failure of Organoid Formation
If cells stay scattered as an alternative of clustering, doubtless causes embody poor HE differentiation, low HE viability, or inadequate help throughout preliminary co-culture. The protocol emphasizes the significance of cell viability and acceptable co-culture setup.
Organoid Loss Throughout Medium Adjustments
As a result of organoids are usually not bodily connected to the microwells, careless dealing with can disturb or aspirate them. Light and constant medium trade is vital.
Inconsistent Kupffer Cell Differentiation
This will likely replicate variability in EMP high quality, co-culture situations, or timing. Circulate cytometry at a number of time factors will help observe differentiation dynamics.
Regularly Requested Questions
What are KuLOs?
KuLOs are human iPSC-derived liver organoids containing Kupffer-like cells. They mix hepatic, endothelial, mesenchymal, and hematopoietic-derived immune parts in a three-dimensional organoid mannequin.
What are Kupffer cells?
Kupffer cells are liver-resident macrophages. They assist regulate irritation, clear particles, course of antigens, take part in iron metabolism, and help liver restore.
Why embody Kupffer cells in liver organoids?
Together with Kupffer cells permits organoids to mannequin immune-hepatic interactions. That is vital for finding out liver irritation, sepsis-related dysfunction, drug-induced damage, and tissue restore.
What are EMPs?
EMPs are erythroid-myeloid progenitors. On this protocol, they’re generated from human iPSCs and used as Kupffer cell progenitors.
What markers are used to determine EMPs?
The protocol highlights CD43, CD34, and CD115 as vital EMP-associated markers.
What markers are used to determine Kupffer-like cells?
Kupffer-like cells in KuLOs are characterised utilizing markers equivalent to CD45, CD14, and CD163.
What markers are used to judge hepatic endoderm?
Hepatic endoderm will be assessed utilizing markers equivalent to EpCAM/CD326, CD133, HNF4A, and AFP, together with downregulation of pluripotency markers.
How lengthy does KuLO maturation take?
The co-culture section takes about two weeks. Round day 14, KuLOs are anticipated to point out extra mature hepatic operate and differentiated Kupffer-like cells.
What liver capabilities can KuLOs mannequin?
KuLOs can present albumin secretion, hepatic marker expression, CYP3A4 exercise, ammonia metabolism, and inflammatory response to endotoxin stimulation.
Are KuLOs equal to grownup human liver tissue?
No. KuLOs are superior in vitro fashions, however they continue to be much less mature and fewer structurally advanced than native grownup human liver.
Conclusion
Human iPSC-derived liver organoids containing Kupffer cells symbolize an vital step towards extra real looking in vitro liver fashions. By integrating liver-resident macrophage-like cells right into a multicellular organoid system, KuLOs enable researchers to check immune-hepatic communication in a managed human-cell platform.
The protocol by Li, Nie, and Taniguchi focuses on producing erythroid-myeloid progenitors and hepatic endoderm from human iPSCs, then combining these cells with iPSC-derived endothelial and mesenchymal lineages to ascertain Kupffer cell-containing liver organoids. The ensuing organoids help hepatic maturation, Kupffer-like cell differentiation, inflammatory activation, and restoration after inflammatory problem.
For liver illness analysis, this mannequin is very precious as a result of many liver situations contain communication between hepatocytes and immune cells. Sepsis-related liver dysfunction, inflammatory damage, drug toxicity, regeneration, and continual illness development all contain macrophage-hepatic interactions. KuLOs present a sensible analysis platform for finding out these processes in a human iPSC-derived system.
Though limitations stay, together with incomplete hepatocyte maturity and restricted endothelial community formation, KuLOs supply a extra advanced and biologically related mannequin than hepatocyte-only organoids. As organoid know-how advances, Kupffer cell-containing liver organoids could change into more and more helpful for illness modeling, drug screening, regenerative drugs, and precision hepatology.
Supply Attribution
This text relies on the scientific content material supplied from:
Li, Y., Nie, Y., & Taniguchi, H. “Protocol for producing liver organoids containing Kupffer cells utilizing human iPSCs.” STAR Protocols, Quantity 6, Subject 4, 2025.
Associated referenced work:
Li, Y. et al. “Integration of Kupffer cells into human iPSC-derived liver organoids for modeling liver dysfunction in sepsis.” Cell Experiences, 2024.
